Enzon Pharmaceuticals Inc. (ENZN) Monday reported fourth-quarter net loss of $5.2 million or $0.11 per share, wider than $5.0 million or $0.10 per share reported last year.
Total revenues for the quarter inched up to $10.6 million from $10.0 million last year.
For comments and feedback: editorial@rttnews.com